188 related articles for article (PubMed ID: 32974032)
1. Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis.
Hufnagel DH; Wilson AJ; Saxon J; Blackwell TS; Watkins J; Khabele D; Crispens MA; Yull FE; Beeghly-Fadiel A
Biomark Res; 2020; 8():45. PubMed ID: 32974032
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.
Ok CY; Xu-Monette ZY; Li L; Manyam GC; Montes-Moreno S; Tzankov A; Visco C; Dybkær K; Routbort MJ; Zhang L; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Rao H; Møller MB; Winter JN; Piris MA; Wang SA; Medeiros LJ; Young KH
Mod Pathol; 2015 Sep; 28(9):1202-13. PubMed ID: 26111978
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological implications of nuclear factor κB signal pathway activation in diffuse large B-cell lymphoma.
Zhao Q; Fu W; Jiang H; Du J; Zhang C; Xi H; Zhou F; Li R; Hou J
Hum Pathol; 2015 Apr; 46(4):524-31. PubMed ID: 25636172
[TBL] [Abstract][Full Text] [Related]
4. p52 expression enhances lung cancer progression.
Saxon JA; Yu H; Polosukhin VV; Stathopoulos GT; Gleaves LA; McLoed AG; Massion PP; Yull FE; Zhao Z; Blackwell TS
Sci Rep; 2018 Apr; 8(1):6078. PubMed ID: 29666445
[TBL] [Abstract][Full Text] [Related]
5. NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer.
Puvvada SD; Funkhouser WK; Greene K; Deal A; Chu H; Baldwin AS; Tepper JE; O'Neil BH
Oncology; 2010; 78(3-4):181-8. PubMed ID: 20414006
[TBL] [Abstract][Full Text] [Related]
6. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
8. NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression.
Uno M; Saitoh Y; Mochida K; Tsuruyama E; Kiyono T; Imoto I; Inazawa J; Yuasa Y; Kubota T; Yamaoka S
PLoS One; 2014; 9(2):e88347. PubMed ID: 24533079
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study.
Lessard L; Bégin LR; Gleave ME; Mes-Masson AM; Saad F
Br J Cancer; 2005 Oct; 93(9):1019-23. PubMed ID: 16205698
[TBL] [Abstract][Full Text] [Related]
10. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
Kleinberg L; Dong HP; Holth A; Risberg B; Trope' CG; Nesland JM; Flørenes VA; Davidson B
Hum Pathol; 2009 Jun; 40(6):795-806. PubMed ID: 19157506
[TBL] [Abstract][Full Text] [Related]
11. Increased staining for phosphorylated AKT and nuclear factor-kappaB p65 and their relationship with prognosis in epithelial ovarian cancer.
Guo RX; Qiao YH; Zhou Y; Li LX; Shi HR; Chen KS
Pathol Int; 2008 Dec; 58(12):749-56. PubMed ID: 19067848
[TBL] [Abstract][Full Text] [Related]
12. High Expression of Nuclear Transcription Factor-κB is Associated with Cisplatin Resistance and Prognosis for Ovarian Cancer.
Kan Y; Liu J; Li F
Cancer Manag Res; 2020; 12():8241-8252. PubMed ID: 32982420
[TBL] [Abstract][Full Text] [Related]
13. Activation of the non-canonical NF-κB/p52 pathway in vascular endothelial cells by RANKL elicits pro-calcific signalling in co-cultured smooth muscle cells.
Harper E; Rochfort KD; Forde H; Davenport C; Smith D; Cummins PM
Cell Signal; 2018 Jul; 47():142-150. PubMed ID: 29678621
[TBL] [Abstract][Full Text] [Related]
14. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
[TBL] [Abstract][Full Text] [Related]
15. IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.
House CD; Grajales V; Ozaki M; Jordan E; Wubneh H; Kimble DC; James JM; Kim MK; Annunziata CM
BMC Cancer; 2018 May; 18(1):595. PubMed ID: 29801480
[TBL] [Abstract][Full Text] [Related]
16. Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma.
Darb-Esfahani S; Sinn BV; Weichert W; Budczies J; Lehmann A; Noske A; Buckendahl AC; Müller BM; Sehouli J; Koensgen D; Györffy B; Dietel M; Denkert C
Histopathology; 2010 May; 56(6):727-39. PubMed ID: 20546338
[TBL] [Abstract][Full Text] [Related]
17. Determining the prognostic significance of IKKα in prostate cancer.
Montes M; MacKenzie L; McAllister MJ; Roseweir A; McCall P; Hatziieremia S; Underwood MA; Boyd M; Paul A; Plevin R; MacKay SP; Edwards J
Prostate; 2020 Oct; 80(14):1188-1202. PubMed ID: 33258506
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer.
Annunziata CM; Stavnes HT; Kleinberg L; Berner A; Hernandez LF; Birrer MJ; Steinberg SM; Davidson B; Kohn EC
Cancer; 2010 Jul; 116(13):3276-84. PubMed ID: 20564628
[TBL] [Abstract][Full Text] [Related]
19. Role for protein kinase Ctheta (PKCtheta) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation.
Li Y; Sedwick CE; Hu J; Altman A
J Biol Chem; 2005 Jan; 280(2):1217-23. PubMed ID: 15536066
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
Liu X; Wang B; Ma X; Guo Y
Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
